Skip to Content

93 9541 (Pemoline 18.75 mg)

Pill imprint 93 9541 has been identified as Pemoline 18.75 mg.

Pemoline is used in the treatment of adhd and belongs to the drug class CNS stimulants. There is no proven risk in humans during pregnancy. Pemoline 18.75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).

Pemoline
Imprint:
93 9541
Strength:
18.75 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
CNS stimulants
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Teva Pharmaceuticals USA

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide